Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations

January 1-4, 2026 | Location to be Determined
Scientific Organizers: Jennifer Guerriero, Thomas Marron, Ira Mellman and Solange Peters

  In Person
  On Demand

January 1-4, 2026 | Location to be Determined
Scientific Organizers: Jennifer Guerriero, Thomas Marron, Ira Mellman and Solange Peters

Available Formats:   = In Person     = On Demand
Thursday, January 1, 2026
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Friday, January 2, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Elizabeth M. Jaffee †, Johns Hopkins University
Cancer Immunotherapy - Where do we Stand Now?
The Failures, Successes and Future of Cancer Immunotherapy
9:00–11:15 AM
Solange Peters, CHUV
Postmortem of Failed Immunotherapy Approaches
Richard Pazdur †, U.S. Food and Drug Administration
Optimal Clinical Trial Endpoints and Designs, Learning from Past Failures
Ira Mellman, Genentech, Inc.
The Future of Cancer Immunotherapy
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Panel Discussion 1: Accelerating Development and Overcoming Regulatory Challenges of Drug Approvals
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Probing Omics and Big Data to Identify Novel Therapeutic Targets and Biomarkers
5:00–7:00 PM
Laurence Zitvogel †, Institut Gustave Roussy
Mining Systemic Inflammation and Microbiome Data to Aid Cancer Detection, Prevention and Treatment
Padmanee Sharma †, University of Texas MD Anderson Cancer Center
Talk Title to be Announced
Özlem Türeci †, BioNTech
Vaccines
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Saturday, January 3, 2026
Breakfast
7:00–8:00 AM
Advances and Challenges of Combination Immunotherapy of Cancer
8:00–11:00 AM
Sandra Demaria †, Weill Cornell Medical College
How to Optimally Combine Radiation and Immunotherapy
Thomas Powles †, Barts Cancer Institute
How to Optimally Combine Chemotherapies and Targeted Therapies with Immunotherapy
Thomas Marron, Icahn School of Medicine at Mount Sinai
Neoadjuvant Combination Immunotherapy Approaches: Improving Outcomes and Propelling the Science
James P. Allison †, University of Texas MD Anderson Cancer Center
The Successes—and Many Failures—of Combination Immunotherapy, and Where we go from Here
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Panel discussion 2: “Lessons Learned” from Combination Therapy: What can be Learned from the Failures to Improve Future Successes in combination Treatment
1:30–3:15 PM
Career Roundtable
3:30–4:30 PM
Coffee Available
4:30–5:00 PM
Novel Approaches for Targeting Myeloid and Stromal Cells in the Tumor Microenvironment
5:00–7:00 PM
David A. Tuveson †, Cold Spring Harbor Laboratory
Targeting Stroma in the Tumor Microenvironment
Karin E. de Visser †, Netherlands Cancer Institute
Crosstalk between Eosinophils and Adaptive Immune Cells: A New Avenue for Immune Checkpoint Blockade
Jennifer Guerriero, Brigham and Women's Hospital
Harnessing Macrophages for Anti-Cancer Therapy
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Sunday, January 4, 2026
Breakfast
7:00–8:00 AM
Novel Insights into Tumor Recognition by Lymphocytes
8:00–11:00 AM
Tullia C. Bruno †, University of Pittsburgh
B Cells
Miriam Merad †, Mount Sinai School of Medicine
Novel Insights into the Organization of TLS
E. John Wherry †, University of Pennsylvania
Novel T Cell Checkpoints
Carl H. June †, University of Pennsylvania
Cellular Therapies
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Workshop: Novel Platforms to Understand Mechanisms of Action and Resistance
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Cancer Immunotherapy: Overcoming Resistance
5:00–6:45 PM
Hélène Salmon †, Institut Curie
Factors of TME Resistance
Charles Swanton †, Francis Crick Institute
Clonal Evolution and Immune Evasion
Christine Carine Moussion †, Genentech, Inc.
In situ Tumor Arrays Reveal Early Environmental Control of Cancer Immunity
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Monday, January 5, 2026
Departure
12:00–11:59 PM

Subscribe for Updates